High materiality7/10
Rapport Therapeutics (RAPP) PT Raised to $75 at BTIG
Why it may matterVerify against the original reporting
Bullish setup based on target upgrade.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish setup based on target upgrade.
What happened, with direct paths to the underlying reporting
BTIG raises RAPP price target to $75; current price is $42.68.
Target: $75
Posted price: $42.68
Analyst firm: BTIG
Analyst: Kambiz Yazdi
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.